FNP 1 Midterm Studyguide
Study online at https://quizlet.com/_ik63yr
1. Acute COPD ex- Increase in usual symptoms in a patient with COPD (worsening cough, sputum,
acerbation and dyspnea)
Viral or bacterial source, environmental factors, MI, CHF, PE, and aspiration
2. Pneumonitis Typically occurs in patients who are debilitated, have neuromuscular problems
affecting swallowing, or with AMS including ETOH
Patients often have concomitant peridontal disease and more indolent symptoms
of putrid cough, fever, and dyspnea evolving over days to weeks
3. Differential DX pneumonia
for: lung cancer
Dyspnea, fever, influenza
purulent cough, PE
hemoptysis
4. Antibiotics for Ceftriaxone
Pneumonia Ceftriaxone and azithromycin
levofloxacin
5. What would be Onset and fever
included in the A sudden onset with fever suggests bacterial, while a vague group of symptoms
history and phys- and subtle onset suggests viral
ical exam that
would help you
differentiate be-
tween bacterial
and viral pharyn-
gitis?
6. What are the two Acute glomerulonephritis and rheumatic fever
major complica-
Page 1
, FNP 1 Midterm Studyguide.pdf 2026
FNP 1 Midterm Studyguide
Study online at https://quizlet.com/_ik63yr
tions of a strep
infection?
7. Name the first Pencillins
line antibiotic Can be given IM or Amoxicillin PO for 10 days
chose for a
GABHS infection
8. Drug allergies Erythromycin can be given if allergic to penicillin, or second generation
and GABHS macrolides
-azithromyicn
-clairthromycin
-cef (1st gen)
-keflex (1st gen)
9. Explain how
glmoerulonephri-
tis and
rheumatic fever
are associated
with strep
infections
10. How do you treat if patient presents with fever, malaise, headache, arthralgia, sore throat, swollen
mononucleosis glands, post-cervical adenopathy, N/V, abd discomfort, or rash consider mono
labs: CBC with diff, monospot, EBV titre
supportive care: rest and fluids
11. Long-acting Beta salmeterol
2 agonists (LABA) formoterol
Page 2
, FNP 1 Midterm Studyguide.pdf 2026
FNP 1 Midterm Studyguide
Study online at https://quizlet.com/_ik63yr
daily use should not exceed 100 mcg of salmeterol or 24 mcg of formoterol
EPR-3 recommends that Labas be used in adjunct to ICS therapy for providing
long-term control of symptoms >12 years of age
12. LABA blackbox not to be used as a monotherapy for asthma
warning not first-line for patients with mild asthma or some with moderate asthma
not appropriate for patients whose asthma worsens while taking chronic LABAS
13. Omalizumab (Xo- -immunomodulator (ant-IgE)
lair) -associated with decreased asthma exacerbations
-reductions in dose of ICS needed to control
14. Omalizumab (xo- used for patient >12 with severe persistent asthma and allergies that are inade-
lair) indications quately controlled with combination of high dose ICS and LABA
15. Xolair caution Must be prepared and equipped to identify and treat anaphylactic reactions
(epinephrine on site)
16. Pneumonia clini- • Cough, fever, SOB,
cal presentation • Sputum production,
• Rales: heard best at the end of inspiration; crackling noise heard best in the
middle lobe (e.g. right mid-axillary space)
• Tachypnea
• Chills, decreased pulse oximetry, chest pain
17. Explain the phys- -infants are obligate nose breathers
iologic differ- -smaller airways, shorter eustatchian tubes
ences in pedi- -thicker alveoli walls
atrics vs. adults -decreased FRV
(Resp & HEENT) -less muscle in small small bronchi (increased r/f pneumonia
-more mucus producing strucures
18.
Page 3